Please assess the completion status of the following clinical trial:

Trial Title: Optimizing Recovery in Abdominoplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Medically cleared to undergo elective surgery (including associated anesthesia) at UW Madison Surgery Center (MSC).~Exclusion Criteria:~* Pregnant or breast-feeding women~* Incarcerated women or men~* Individuals unable to give consent due to another condition such as impaired decision-making capacity.~* Men or women who take opioid pain medications on a regular basis prior to surgery~* Men or women with a history of opioid abuse and/or dependence~* Participants with a history of bleeding disorders precluding safe abdominoplasty~* Participants on anticoagulation therapy who have not held their anticoagulation as recommended by their surgeon or anesthesiologist~* Participants not medically cleared for surgery at Madison Surgery Center. This would include participants with sepsis/bacteremia, significant valvular disorders or heart conditions.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Liposomal Bupivacaine (Type: ACTIVE_COMPARATOR): Participants in this study arm will receive intraoperative injection of Liposomal Bupivacaine mixed with Bupivacaine to the abdominal wall.
- Bupivacaine (Type: OTHER): Participants in this study arm will receive intraoperative injection of bupivacaine without Liposomal bupivacaine to the abdominal wall.

Based on this trial design, predict the completion outcome and termination type (if applicable).